Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
A(2A) adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients
A(2A) Adenosine Receptors Are Differentially Modulated by Pharmacological Treatments in Rheumatoid Arthritis Patients and Their Stimulation Ameliorates Adjuvant-Induced Arthritis in Rats
A(2A) adenosine receptors and Parkinson%26apos;s disease severity
A(2A) adenosine receptor deletion is protective in a mouse model of Tauopathy
A(2A) Receptor Ligands: Past, Present and Future Trends
A(2A) adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson's disease
A(2A) adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus
A(2A) adenosine receptor agonists reduce both high-palatability and low-palatability food intake in female rats
A(2A) adenosine receptor regulates glia proliferation and pain after peripheral nerve injury
A(2A) Adenosine Receptor Binding Parameters in Platelets from Patients Affected by Pathological Gambling
A(2A) Adenosine Receptor (A(2A)AR) as a Therapeutic Target in Diabetic Retinopathy
A(2A) adenosine receptor and its modulators: Overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists
A(2A) Receptor Antagonism and Dyskinesia in Parkinson%26apos;s Disease
A(2A) receptor antagonists do not induce dyskinesias in drug-naive or L-dopa sensitized rats
A(2A) receptors in inflammation and injury: lessons learned from transgenic animals
A(2A) receptor knockout worsens survival and motor behaviour in a transgenic mouse model of Huntington's disease
A(2A)/D-2 receptor heteromerization in a model of Parkinson%26apos;s disease. Focus on striatal aminoacidergic signaling
A(2A) and A(3) adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release
A(2A) adenosine receptor ligand binding and signalling is allosterically modulated by adenosine deaminase
A(2A) adenosine receptor (AR) activation inhibits pro-inflammatory cytokine production by human CD4(+) helper T cells and regulates Helicobacter-induced gastritis and bacterial persistence
A(2A) adenosine receptors control pancreatic dysfunction in high-fat-diet-induced obesity
A(2A) Adenosine Receptor Antagonism Reverts the Blood-Brain Barrier Dysfunction Induced by Sleep Restriction
A(2A) adenosine receptor function in patients with vasovagal syncope
A(2A) Adenosine Receptor Antagonists as Therapeutic Candidates: Are They Still an Interesting Challenge?
A(2B) adenosine receptor contributes to penile erection via PI3K/AKT signaling cascade-mediated eNOS activation
A(2B) Adenosine Receptor-Mediated Induction of IL-6 Promotes CKD
A(2B) adenosine receptor blockade inhibits growth of prostate cancer cells
A(2B) Adenosine Receptor Expression by Myeloid Cells Is Proinflammatory in Murine Allergic-Airway Inflammation
A(2B) Receptor Ligands: Past, Present and Future Trends
A(2B) Adenosine Receptors Protect against Sepsis-Induced Mortality by Dampening Excessive Inflammation
A(2B) adenosine receptors in immunity and inflammation
A(2B) adenosine receptors regulate the mucus clearance component of the lung's innate defense system
A(2B)AR expression in non-immune cells plays an important role in the development of murine colitis
A(2B) Adenosine Receptor Induces Protective Antihelminth Type 2 Immune Responses
A(2B) adenosine receptors inhibit superoxide production from mitochondrial complex I in rabbit cardiomyocytes via a mechanism sensitive to Pertussis toxin
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway
A(2B) receptors mediate the induction of early genes and inhibition of arterial smooth muscle cell proliferation via Epac
A(2B) or not 2B: that is the question
A(2B) adenosine receptor antagonists: Design, synthesis and biological evaluation of novel xanthine derivatives
A(2a) Adenosine Receptor Mediates PKA-Dependent Glutamate Release from Synaptic-like Vesicles and Ca2+ Efflux from an IP3- and Ryanodine-Insensitive Intracellular Calcium Store in Astrocytes
A(2a) and a(2b) adenosine receptors affect HIF-1 alpha signaling in activated primary microglial cells
A(2b) adenosine receptors can change their spots
A(2b) Adenosine Receptor Regulates Hyperlipidemia and Atherosclerosis
A(2b) adenosine receptors in cardioprotection: Timing is everything
A(3) Adenosine Receptor Allosteric Modulator Induces an Anti-Inflammatory Effect: In Vivo Studies and Molecular Mechanism of Action
A(3) Adenosine Receptors Mediate Oligodendrocyte Death and Ischemic Damage to Optic Nerve
A(3)-Coupling catalyzed by robust Au nanoparticles covalently bonded to HS-functionalized cellulose nanocrystalline films
A(3)- Coupling Reaction as a Strategy Towards the Synthesis of Alkaloids
A(3) Adenosine Receptor Antagonist, Truncated Thio-Cl-IB-MECA, Induces Apoptosis in T24 Human Bladder Cancer Cells
A(3) Receptor Ligands: Past, Present and Future Trends
A(3) adenosine receptor activation during reperfusion reduces infarct size through actions on bone marrow-derived cells
A(3)V(5)O(14) (A = K+, Rb+, or TI+), New Polar Oxides with a Tetragonal Tungsten Bronze Related Structural Topology: Synthesis, Structure, and Functional Properties
A(3) adenosine receptor agonist, CF102, protects against hepatic ischemia/reperfusion injury following partial hepatectomy
A(3)B-Type Phthalocyanine-Based Homoleptic Lanthanide(III) Double-Decker pi-Radical Complexes Bearing Functional Hydroxy Groups: Synthetic Approach, Spectral Properties and Electrochemical Study
A(3) adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways
A(3)-type star polymers via click chemistry
A(3) Adenosine Receptor-Mediated p53-Dependent Apoptosis in Lu-65 Human Lung Cancer Cells
A(3) Adenosine Receptor Mediates Apoptosis in 5637 Human Bladder Cancer Cells by G(q) Protein/PKC-Dependent AIF Upregulation
A(3) Adenosine Receptor Mediates Apoptosis in In Vitro RCC4-VHL Human Renal Cancer Cells by Up-Regulating AMID Expression
A(3)B intermetallics: Defect chemistry and nonstoichiometry
A(3)srC: Autonomic Assessment Approach to IOT Security Risk Based on Multidimensional Normal Cloud
A(3) Receptors Are Overexpressed in Pleura from Patients with Mesothelioma and Reduce Cell Growth via Akt/Nuclear Factor-kappa B Pathway
A(3)V(2)(PO4)(3) (A = Na or Li) probed by in situ X-ray absorption spectroscopy
A(3)-PROOF OF STRUCTURE THEOREMS FOR CHEVALLEY GROUPS OF TYPES E-6 AND E-7 II. MAIN LEMMA
A(3) Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy
A(3)-Type star stilbene and cyanostilbene molecules: synthesis, fluorescence properties and bio-imaging application
A(4): Asynchronous Adaptive Anti-Aliasing using Shared Memory
A(4) symmetry at colliders and in the universe
A(4)-based neutrino masses with Majoron decaying dark matter
A(4) Family Symmetry from SU(5) SUSY GUTs in 6d
A(4) x U(1)(PQ) model for the lepton flavor structure and the strong CP problem
A(4) see-saw models and form dominance
A(4) model for lepton masses and mixings
A(4) models of tri-bimaximal-reactor mixing
A(4) x SU(5) SUSY GUT of flavour with trimaximal neutrino mixing
A(4) X SU(5) SUSY GUT of flavour in 8d
A(4) flavor symmetry model for Dirac neutrinos and sizable Ue3
A(4) flavor models in split seesaw mechanism
A(4) flavor symmetry and neutrino phenomenology
A(4) family symmetry and quark-lepton unification
A(4) and CP symmetry and a model with maximal CP violation
A(5)RE(4)X[TO4](4) crystal growth and photoluminescence. Fluoride flux synthesis of sodium and potassium rare earth silicate oxyfluorides
A(5)RE(4)X[TO4](4) crystal growth and photoluminescence. Hydroflux synthesis of sodium rare earth silicate hydroxides